|
1
|
Teo YX, White IR. Sodium metabisulphite: Findings on patch testing over 5-years from a single centre. Contact Dermatitis 2024. [PMID: 38838032 DOI: 10.1111/cod.14615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 04/15/2024] [Accepted: 05/22/2024] [Indexed: 06/07/2024]
Affiliation(s)
- Ying X Teo
- Department of Cutaneous Allergy, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK
- Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK
| | - Ian R White
- Department of Cutaneous Allergy, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK
| |
Collapse
|
|
2
|
Ekstein SF, Warshaw EM. Sulfites: Allergen of the Year 2024. Dermatitis 2024; 35:6-12. [PMID: 37590472 DOI: 10.1089/derm.2023.0154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/19/2023]
Abstract
Sodium disulfite, also known as sodium metabisulfite or sodium pyrosulfite, is an inorganic compound, which may cause allergic contact dermatitis. Sulfites act as antioxidants and preservatives; common sources include food/beverages, pharmaceuticals, and personal care products. Importantly, sulfites are not included in most screening patch test series and thus may be missed as a relevant contact allergen. The American Contact Dermatitis Society chose sulfites as the Allergen of the Year for 2024 to raise awareness about this significant allergen.
Collapse
Affiliation(s)
- Samuel F Ekstein
- From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA
- Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA
| | - Erin M Warshaw
- From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA
- Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA
| |
Collapse
|
|
3
|
Johnson H, Yu J. Systemic Contact Dermatitis to Sodium Metabisulfite Presenting As Episodic, Unilateral Lip Swelling. Dermatitis 2023; 34:451. [PMID: 37130320 DOI: 10.1089/derm.2023.0039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Affiliation(s)
- Hadley Johnson
- From the University of Minnesota Medical School, Minneapolis, Minnesota, USA
| | - JiaDe Yu
- Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| |
Collapse
|
|
4
|
Warshaw EM, Buonomo M, DeKoven JG, Atwater AR, Reeder MJ, Belsito DV, Silverberg JI, Taylor JS, Maibach HI, Zug KA, Sasseville D, Fowler JF, Pratt MD, DeLeo VA, Zirwas MJ. Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018. Contact Dermatitis 2021; 85:285-296. [PMID: 33843061 DOI: 10.1111/cod.13860] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2021] [Revised: 03/23/2021] [Accepted: 04/07/2021] [Indexed: 01/09/2023]
Abstract
BACKGROUND Sodium disulfite (SD), also known as sodium metabisulfite, is an increasingly recognized cause of allergic contact dermatitis. OBJECTIVES The objective of this work was to characterize individuals with positive patch test reactions to SD as well as analyse reaction strength, clinical relevance, and sources. METHODS This is a retrospective analysis of patients patch tested with SD (1% petrolatum) by the North American Contact Dermatitis Group (NACDG), 2017 to 2018. RESULTS Of 4885 patients patch tested with SD, 132 (2.7%) had a positive reaction. Common primary anatomic sites of dermatitis were face (28.8%), hands (20.5%), and a scattered/generalized distribution (13.6%). Compared with SD-negative patients, SD-positive patients were more likely male (odds ratio 2.81, 95% confidence interval 1.98-4.00) and/or over 40 years (odds ratio 1.95, 95% confidence interval 1.30-2.94). Reactions were most commonly + (50.4%) or ++ (34.1%); 65.2% were considered currently relevant. About 15.2% were definitively confirmed in sources, commonly personal care products (18.9%, especially hair dye), and drugs/medications/alcoholic beverages (9.1%). Only 2.3% of positive reactions were linked to occupation. CONCLUSIONS Positive reactions to SD occurred in 2.7% of tested patients. Reactions were often clinically relevant and linked to personal care products and drugs/medications/alcoholic beverages.
Collapse
Affiliation(s)
- Erin M Warshaw
- Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.,Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.,Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA
| | - Michele Buonomo
- Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.,Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.,University of Minnesota Medical School, Minneapolis, Minnesota, USA
| | - Joel G DeKoven
- Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
| | - Amber R Atwater
- Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA
| | - Margo J Reeder
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
| | - Donald V Belsito
- Department of Dermatology, Columbia University Irving Medical School, New York, New York, USA
| | - Jonathan I Silverberg
- Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA
| | - James S Taylor
- Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA
| | - Howard I Maibach
- Department of Dermatology, University of California San Francisco, San Francisco, California, USA
| | - Kathryn A Zug
- Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
| | - Denis Sasseville
- Division of Dermatology, Montreal General Hospital, McGill University, Montreal, Quebec, Canada
| | - Joseph F Fowler
- Division of Dermatology, University of Louisville, Louisville, Kentucky, USA
| | - Melanie D Pratt
- Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada
| | - Vincent A DeLeo
- Department of Dermatology, Keck School of Medicine, Los Angeles, California, USA
| | - Matt J Zirwas
- Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio, USA
| |
Collapse
|
|
7
|
Borgemeester RWK, van Laar T, Schuttelaar MLA. Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases. Contact Dermatitis 2018; 79:316-318. [DOI: 10.1111/cod.13058] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Accepted: 06/02/2018] [Indexed: 11/28/2022]
Affiliation(s)
- Robbert W. K. Borgemeester
- Parkinson Expertise Centre; University Medical Centre Groningen, University of Groningen; Groningen The Netherlands
| | - Teus van Laar
- Parkinson Expertise Centre; University Medical Centre Groningen, University of Groningen; Groningen The Netherlands
| | - Marie L. A. Schuttelaar
- Department of Dermatology; University Medical Centre Groningen, University of Groningen; Groningen The Netherlands
| |
Collapse
|
|
9
|
Borges AS, Valejo Coelho MM, Fernandes C, Brasileiro A, Gonçalo M. Systemic allergic dermatitis caused by sodium metabisulfite in rectal enemas. Contact Dermatitis 2018; 78:429-430. [DOI: 10.1111/cod.12971] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2017] [Accepted: 12/27/2017] [Indexed: 11/28/2022]
Affiliation(s)
- Ana S. Borges
- Dermatology and Venereology Department, Hospital Santo António dos CapuchosCentro Hospitalar de Lisboa Central 1169‐050 Lisbon Portugal
| | - Margarida M. Valejo Coelho
- Dermatology and Venereology Department, Hospital Santo António dos CapuchosCentro Hospitalar de Lisboa Central 1169‐050 Lisbon Portugal
| | - Cândida Fernandes
- Dermatology and Venereology Department, Hospital Santo António dos CapuchosCentro Hospitalar de Lisboa Central 1169‐050 Lisbon Portugal
| | - Ana Brasileiro
- Dermatology and Venereology Department, Hospital Santo António dos CapuchosCentro Hospitalar de Lisboa Central 1169‐050 Lisbon Portugal
| | - Margarida Gonçalo
- Clinic of Dermatology, University Hospital and Faculty of MedicineUniversity of Coimbra 3000‐075 Coimbra Portugal
| |
Collapse
|
|
10
|
Abstract
The International Contact Dermatitis Research Group proposes a classification for the clinical presentation of contact allergy. The classification is based primarily on the mode of clinical presentation. The categories are direct exposure/contact dermatitis, mimicking or exacerbation of preexisting eczema, multifactorial dermatitis including allergic contact dermatitis, by proxy, mimicking angioedema, airborne contact dermatitis, photo-induced contact dermatitis, systemic contact dermatitis, noneczematous contact dermatitis, contact urticaria, protein contact dermatitis, respiratory/mucosal symptoms, oral contact dermatitis, erythroderma/exfoliative dermatitis, minor forms of presentation, and extracutaneous manifestations.
Collapse
|
|
11
|
Uter W, Spiewak R, Cooper SM, Wilkinson M, Sánchez Pérez J, Schnuch A, Schuttelaar ML. Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012. Pharmacoepidemiol Drug Saf 2016; 25:1305-1312. [DOI: 10.1002/pds.4064] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2016] [Revised: 06/21/2016] [Accepted: 06/21/2016] [Indexed: 11/07/2022]
Affiliation(s)
- Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology; University of Erlangen/Nürnberg; Erlangen Germany
| | - Radoslaw Spiewak
- Department of Experimental Dermatology and Cosmetology, Faculty of Pharmacy; Jagiellonian University Medical College; Krakow Poland
| | | | - Mark Wilkinson
- Department of Dermatology; Chapel Allerton Hospital; Leeds UK
| | | | - Axel Schnuch
- Information Network of Departments of Dermatology (IVDK); University Medicine Göttingen; Göttingen Germany
| | - Marie-Louise Schuttelaar
- Department of Dermatology; University Medical Centre Groningen, University of Groningen; Groningen the Netherlands
| |
Collapse
|